Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Supernus Pharmaceuticals, Inc.”

68 pharma patents match "Supernus Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 68
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 68 pharmaceutical patents matching "Supernus Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

68 results for “Supernus Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 9549940

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  2. US 9434703

    Viloxazine compositions

    Supernus Pharmaceuticals, Inc. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted

  3. US 9403783

    Methods for producing viloxazine salts and novel polymorphs thereof

    Supernus Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  4. US 9393203

    Osmotic drug delivery system

    Supernus Pharmaceuticals, Inc. · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  5. US 9370525

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  6. US 9358204

    Formulations of viloxazine

    Supernus Pharmaceuticals, Inc. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  7. US 9351975

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted

  8. US 9308176

    Less abusable pharmaceutical preparations

    Supernus Pharmaceuticals, Inc. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  9. US 9144551

    Drug formulations having reduced abuse potential

    Supernus Pharmaceuticals, Inc. · Granted Sep 29, 2015 · Expires Sep 24, 2035

    granted

  10. US 9119791

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  11. US 9119792

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted

  12. US 8992989

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  13. US 8906413

    Drug formulations having reduced abuse potential

    Supernus Pharmaceuticals, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  14. US 8889191

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  15. US 8877248

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  16. US 8821930

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  17. US 8808714

    Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics

    Supernus Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  18. US 8748472

    Stabilized formulations of CNS compounds

    Supernus Pharmaceuticals, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  19. US 8747897

    Osmotic drug delivery system

    Supernus Pharmaceuticals, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  20. US 8709476

    Compositions of quaternary ammonium compounds containing bioavailability enhancers

    Supernus Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  21. US 8709478

    Once daily formulations of tetracyclines

    Supernus Pharmaceuticals, Inc. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  22. US 8663683

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  23. US 8617600

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  24. US 8598191

    Controlled release compositions of gamma-hydroxybutyrate

    Supernus Pharmaceuticals, Inc. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.